There was a negative correlation between CD3+ and CD4+ cells and OS in smoking stage II female lung cancer patients (PCC = 0.626, P<0.05; PCC = 0.534, P<0.05, respectively) (Figure S3). The gene discussed is CD4; the disease is lung carcinoma.